These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28790818)

  • 1. Peptide-modified nanoparticles inhibit formation of
    Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
    Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
    Mahmoud MY; Demuth DR; Steinbach-Rankins JM
    J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
    Mahmoud MY; Steinbach-Rankins JM; Demuth DR
    J Control Release; 2019 Mar; 297():3-13. PubMed ID: 30690103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii.
    Daep CA; Novak EA; Lamont RJ; Demuth DR
    Infect Immun; 2011 Jan; 79(1):67-74. PubMed ID: 21041492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.
    Daep CA; James DM; Lamont RJ; Demuth DR
    Infect Immun; 2006 Oct; 74(10):5756-62. PubMed ID: 16988253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.
    Daep CA; Novak EA; Lamont RJ; Demuth DR
    Peptides; 2010 Dec; 31(12):2173-8. PubMed ID: 20800634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation.
    Bagaitkar J; Daep CA; Patel CK; Renaud DE; Demuth DR; Scott DA
    PLoS One; 2011; 6(11):e27386. PubMed ID: 22110637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.
    Desai H; Mahmoud MY; Tan J; Minooei F; Demuth DR; Steinbach-Rankins JM
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32882864
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics.
    Rocco CJ; Davey ME; Bakaletz LO; Goodman SD
    Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation.
    Patil PC; Tan J; Demuth DR; Luzzio FA
    Bioorg Med Chem; 2016 Nov; 24(21):5410-5417. PubMed ID: 27647373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.
    Lamont RJ; El-Sabaeny A; Park Y; Cook GS; Costerton JW; Demuth DR
    Microbiology (Reading); 2002 Jun; 148(Pt 6):1627-1636. PubMed ID: 12055284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain.
    Daep CA; Lamont RJ; Demuth DR
    Infect Immun; 2008 Jul; 76(7):3273-80. PubMed ID: 18474648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Release Polymeric Fibers for Inhibition of
    Mahmoud MY; Sapare S; Curry KC; Demuth DR; Steinbach-Rankins JM
    Front Chem; 2019; 7():926. PubMed ID: 32039149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii.
    Valappil SP; Coombes M; Wright L; Owens GJ; Lynch RJ; Hope CK; Higham SM
    Acta Biomater; 2012 May; 8(5):1957-65. PubMed ID: 22314314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lactoferrin on oral bacterial attachment.
    Arslan SY; Leung KP; Wu CD
    Oral Microbiol Immunol; 2009 Oct; 24(5):411-6. PubMed ID: 19702956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis.
    Hashino E; Kuboniwa M; Alghamdi SA; Yamaguchi M; Yamamoto R; Cho H; Amano A
    Mol Oral Microbiol; 2013 Dec; 28(6):435-51. PubMed ID: 23890177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm formation by Porphyromonas gingivalis and Streptococcus gordonii.
    Cook GS; Costerton JW; Lamont RJ
    J Periodontal Res; 1998 Aug; 33(6):323-7. PubMed ID: 9777582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of functional salivary peptide by Streptococcus gordonii which inhibits fimbria-mediated adhesion of Porphyromonas gingivalis.
    Kataoka K; Amano A; Kawabata S; Nagata H; Hamada S; Shizukuishi S
    Infect Immun; 1999 Aug; 67(8):3780-5. PubMed ID: 10417138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis.
    Sweidan A; Chollet-Krugler M; Sauvager A; van de Weghe P; Chokr A; Bonnaure-Mallet M; Tomasi S; Bousarghin L
    Fitoterapia; 2017 Sep; 121():164-169. PubMed ID: 28736072
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tan J; Patil PC; Luzzio FA; Demuth DR
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.